|
HEATR5A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.08950000027508E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.62780000000562E-05 |
| Normal-vs-Stage2 |
1.757780E-03 |
| Normal-vs-Stage3 |
3.81160000006986E-07 |
| Normal-vs-Stage4 |
1.51360002309531E-09 |
| Stage1-vs-Stage2 |
7.056800E-01 |
| Stage1-vs-Stage3 |
1.214770E-01 |
| Stage1-vs-Stage4 |
1.962800E-03 |
| Stage2-vs-Stage3 |
1.512180E-01 |
| Stage2-vs-Stage4 |
9.419200E-03 |
| Stage3-vs-Stage4 |
1.540770E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.93380000004895E-06 |
| Normal-vs-AfricanAmerican |
4.189900E-04 |
| Normal-vs-Asian |
1.78398999999274E-05 |
| Caucasian-vs-AfricanAmerican |
7.471000E-01 |
| Caucasian-vs-Asian |
4.127600E-01 |
| AfricanAmerican-vs-Asian |
7.062200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.06260000044234E-07 |
| Normal-vs-Female |
9.83309999980087E-07 |
| Male-vs-Female |
3.589400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.377300E-04 |
| Normal-vs-Age(41-60Yrs) |
9.33110000378434E-08 |
| Normal-vs-Age(61-80Yrs) |
5.59059999960532E-07 |
| Normal-vs-Age(81-100Yrs) |
2.107700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.021700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.695700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.796000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.538600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.743000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.235800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.001630E-01 |
| Classical-VS-Follicular |
3.456600E-01 |
| Classical-VS-Other |
2.711400E-01 |
| Classical-VS-Normal |
1.96135999999125E-05 |
| Tall-VS-Follicular |
5.070400E-01 |
| Tall-VS-Other |
6.195600E-01 |
| Tall-VS-Normal |
1.66564999999341E-05 |
| Follicular-VS-Other |
4.469200E-01 |
| Follicular-VS-Normal |
1.85767999999475E-05 |
| Other-VS-Normal |
3.338400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.32309999961922E-07 |
| Normal-vs-N1 |
2.32989999999766E-05 |
| N0-vs-N1 |
5.160600E-01 |
|
|
